Sung-Bae Kim and Hope Rugo: Oral Paclitaxel Non-Inferior to IV in Metastatic Breast Cancer
Sung-Bae Kim, Professor at Asan Medical Center, Institute for Innovative Cancer Research, shared on X: “Our OPTIMAL trial is now in print in the July 2026, Annals of Oncology. Oral […]
Read the full article2d agoen
You might also wanna read
Paolo Tarantino: Ten Reasons to Favor the Gedatolisib Doublet Over the Triplet
OncoDaily·43m ago
Shuming Zhang: Spatial QSP Model Identifies Fibroblast-Driven Immunotherapy Resistance in HCC
OncoDaily·5h ago
Modular Antibody–ADC Click Chemistry Overcomes Tumor Drug Resistance in Mice
GEN·9h ago
Sandra Misale: Intercepting PDAC in High-risk Individuals by KRAS-Targeting Vaccine
OncoDaily·10h ago
Anthony Letai: Research Shows How AI May Help Guide Care For People With Glioblastoma
OncoDaily·11h ago
Anirban Maitra։ KRAS-Targeted Vaccine Feasibility in High-Risk Individuals for Pancreatic Cancer
OncoDaily·11h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.